Aion Therapeutic Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANTCF research report →
About the company
Aion Therapeutic Inc. operates within Canada, focusing on the provision of medicinal cannabis products. The company, which commenced operations in 2011, adopted its current name, Aion Therapeutic Inc.
- CEO
- John Graham Simmonds Jr.
- IPO
- 2021
- Employees
- 5
- HQ
- Vancouver, ON, CA
Price Chart
- Market Cap
- $2.07M
- P/E
- -0.21
- P/S
- 6.76
- P/B
- -0.34
- EV/EBITDA
- -0.74
- Div Yield
- 0.00%
- Gross Margin
- 44.39%
- Op Margin
- -324.09%
- Net Margin
- -1710.90%
- ROE
- 190.59%
- ROIC
- 66.52%
- Revenue
- $367.48K · 0.00%
- Net Income
- $-6,287,196 · -2349.64%
- EPS
- $-0.02 · -1216.67%
- Op Income
- $-1,190,949
- FCF YoY
- -1941.32%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.48
- Avg Volume
- 3.05K
Get TickerSpark's AI analysis on ANTCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ANTCF coverage
Recent articles, reports, and earnings notes.
No research on ANTCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ANTCF report →Similar companies
Peers in the same neighborhood.